Abstract
Outcomes, Toxicities, and Patterns of Use of Programmed Death-1 (PD-1) Inhibitors in Hodgkin Lymphoma Patients in the United States: A Multicenter Retrospective Study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have